LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer.

Du, Liqin; Zhao, Zhenze; Suraokar, Milind; Shelton, Spencer S; Ma, Xiuye; Hsiao, Tzu-Hung; Minna, John D; Wistuba, Ignacio; Pertsemlidis, Alexander

Du, Liqin; Zhao, Zhenze; Suraokar, Milind; Shelton, Spencer S; Ma, Xiuye; Hsiao, Tzu-Hung; Minna, John D; Wistuba, Ignacio; Pertsemlidis, Alexander.

Afiliación

Du L; Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas, USA.
Zhao Z; Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas, USA.
Suraokar M; Departments of Pathology and Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Shelton SS; Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas, USA.
Ma X; Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, Texas, USA.
Hsiao TH; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Minna JD; Hamon Center for Therapeutic Oncology Research and Departments of Pharmacology and Internal Medicine, UT Southwestern Medical Center at Dallas, Dallas, Texas, USA.
Wistuba I; Departments of Pathology and Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Pertsemlidis A; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, Texas, USA.

Oncotarget ; 9(51): 29601-29618, 2018 Jul 03.

Article en En | MEDLINE | ID: mdl-30038707

Palabras clave

LMO1; TTK; lung cancer; neuroendocrine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google